Equipoise, Trust, and the Need for Cardiologists to Randomly Assign Patients Into Anticoagulation Trials in the Time of COVID.

Ridker, Paul M; Ortel, Thomas L; Hochman, Judith S

Ridker, Paul M; Ortel, Thomas L; Hochman, Judith S.

Ridker PM; Brigham and Women's Hospital, Harvard Medical School, Boston, MA (P.M.R.).
Ortel TL; Duke University School of Medicine, Durham, NC (T.L.O.).
Hochman JS; New York University Langone Health, New York (J.S.H.).

Circulation ; 142(24): 2296-2298, 2020 Dec 15.

Article in English | MEDLINE | ID: covidwho-977574

Subject(s)

Anticoagulants/therapeutic use; COVID-19; Cardiologists; Physician's Role; Randomized Controlled Trials as Topic; Attitude of Health Personnel; Humans; Patient Selection

Keywords

COVID-19; clinical trial protocols; heparin; post-exposure prophylaxis; randomized controlled trial

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Physician's Role / Randomized Controlled Trials as Topic / Cardiologists / COVID-19 / Anticoagulants Type of study: Experimental Studies / Prognostic study / Randomized controlled trials Limits: Humans Language: English Journal: Circulation Year: 2020 Document Type: Article

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google